IBD Evidence

Simptomi

Dzīvošana ar IBD: nogurums, sāpes un neizmērītās daļas

Remisija uz papīra un remisija kā pieredze ir atšķirīgas lietas, un plaisa ir vieta, kur dzīvo lielākā daļa sloga.

Atjaunināts 2 minūtes lasīšanai 40 citāti Pierādījumu stiprums 3/5

Ielas skats uz stacijas aptiekas ēku Bautzenā, Vācijā
Fiver, der Hellseher · CC BY-SA 4.0 · Wikimedia Commons

Nogurums

Nogurums ir viens no visbiežāk ziņotajiem simptomiem IBD un viens no vismazāk ārstētajiem. Tas saglabājas lielā daļā cilvēku, kuru iekaisums ir kontrolēts, kas nozīmē, ka tas nav vienkārši slimības aktivitātes rādītājs.

Iemesli ietver anēmiju (dzelzs deficīts ir ļoti izplatīts un labojams), miega traucējumus, medikamentu ietekmi, hronisku iekaisumu un psiholoģisko slogu neparedzamas slimības dēļ. Labojamie iemesli ir vērts tieši risināt, jo neviens tos neizvirzīs jums piecpadsmit minūšu vizītē, kas koncentrējas uz kalprotektīnu.

Noguruma slogs IBD

Garīgā veselība

Trauksmes un depresijas rādītāji IBD ievērojami pārsniedz fona rādītājus. Acīmredzamais skaidrojums — dzīvot ar neparedzamu, stigmatizētu, dažreiz inkontinenci izraisošu slimību ir satraucoši — ir reāls un, iespējams, ne viss stāsts, ņemot vērā iekaisuma un zarnu-smadzeņu ceļus, kas ir aptverti mūsu zarnu-smadzeņu pierādījumu vietnē.

Praktiski svarīgi ir tas, ka tas ir ārstējams un regulāri tiek palaists garām. Psiholoģiskā atbalsta sniegšana ir daļa no IBD aprūpes Eiropas vadlīnijās un tiek sniegta nevienmērīgi.

Praktiskais slogs

  • Tualetes pieejamības trauksme, kas ierobežo ceļošanu, darbu un sociālo dzīvi vairāk, nekā klīnicisti parasti novērtē.
  • Neparedzamība. Plānošana ir grūta, kad uzliesmojums var notikt bez brīdinājuma.
  • Diētas pārvaldība. Individuālie izraisītāji, nav apstiprinātas saraksta, un liels daudzums pretrunīgu padomu — skatiet diētu.
  • Darbs. Nogurums un steiga slikti mijiedarbojas ar stingriem darba modeļiem.
  • Ceļošana. Medikamentu uzglabāšana, pārtikas drošība un pieejamība — aptverta mūsu ceļojumu veselības vietnē.

Epidemioloģija

IBD incidence ir augsta un stabila Eiropā un Ziemeļamerikā un strauji pieaug jaunattīstības valstīs. Šī ģeogrāfiskā aina ir viens no spēcīgākajiem argumentiem par vides komponentu — diēta, higiēna, antibiotikas un mikrobioms ir visi kandidāti, un neviens nav pierādīts.

Biežāk uzdotie jautājumi

Kāpēc esmu tik noguris, ja esmu remisijā?
Nogurums bieži saglabājas arī pēc iekaisuma kontroles panākšanas. Vispirms pārbaudiet feritīnu un B12 vitamīnu — tie ir bieži sastopami, koriģējami un bieži vien netiek pamanīti trūkumi.
Vai stress izraisa manus paasinājumus?
Stress, iespējams, ietekmē simptomus, taču pierādījumi, ka tas izraisa iekaisumu, ir vājāki, nekā liek domāt tautas uzskati. Tā nav jūsu vaina.
Vai man būs nepieciešama operācija?
Ievērojamai mazākajai daļai pacientu tā ir nepieciešama, un šī daļa ir samazinājusies, jo efektīva terapija tiek uzsākta agrāk — skatīt ārstēšana.
Vai es varu ceļot?
Jā, plānojot medikamentus, apdrošināšanu un pārtikas drošību.
Zemes stāva aptiekas telpas Teltower Damm, Berlīnē-Zehlendorfā, Vācijā
Singlespeedfahrer · CC0 · Wikimedia Commons

Saistītā literatūra

Pierādījumi, kas atbalsta šo lapu Sakārtota joslu diagramma, kas parāda 20 publikāciju, kas minētas šajā lapā, sastāvu pēc pētījumu veida. 14352meta-analysis (14)randomised trial (3)review (5)other (2)
24 publikācijas, 2015–2025. Tas ir maisījums, kurā ir gan pētījumi, gan sintēzes, no kuras ir saprātīgi izdarīt apgalvojumu par cēloņsakarību. Avots: šīs lapas pašu citātu saraksts, zemāk.

Atsauces

Katrs zemāk minētais citāts saista ar oriģinālo recenzēto ierakstu PubMed vai caur DOI. Nekas šeit nav aizvietotājs medicīnas padomam.

  1. Evaluating the causal connections between sleep duration and disease prevalence: A comprehensive systematic review and meta-analysis of Mendelian randomization studies Wang Z, Yao L, Tu M · Medicine · 2026 · Meta-analysis DOIPubMed 41517697Full text
  2. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization Assa A, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40528309
  3. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation Wine E, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40677018Full text
  4. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease Felipez LM, Ali S, de Zoeten EF, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40692184Full text
  5. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  6. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes Zheng T, Roda G, Zabana Y, et al. · Journal of Crohn's & colitis · 2024 · Meta-analysis DOIPubMed 37768647
  7. Acute severe ulcerative colitis trials: the past, the present and the future Honap S, Jairath V, Sands BE, et al. · Gut · 2024 · Systematic review DOIPubMed 38834296Full text
  8. Vitamin D for the treatment of inflammatory bowel disease Wallace C, Gordon M, Sinopoulou V, et al. · The Cochrane database of systematic reviews · 2023 · Systematic review DOIPubMed 37781953Full text
  9. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses Buie MJ, Quan J, Windsor JW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · Meta-analysis DOIPubMed 35863682
  10. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  11. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review Kuenzig ME, Fung SG, Marderfeld L, et al. · Gastroenterology · 2022 · Systematic review DOIPubMed 34995526
  12. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  13. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090
  14. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  15. Pediatric Psoriasis Comorbidities Kittler NW, Cordoro KM · Skin therapy letter · 2020 · Clinical guideline PubMed 33196156
  16. Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review Helsel BC, Williams JE, Lawson K, et al. · Digestive diseases and sciences · 2018 · Systematic review DOIPubMed 29663265
  17. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, et al. · Gastroenterologia y hepatologia · 2018 · Systematic review DOIPubMed 29275001
  18. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I Knowles SR, Graff LA, Wilding H, et al. · Inflammatory bowel diseases · 2018 · Meta-analysis DOIPubMed 29562277
  19. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Ng SC, Shi HY, Hamidi N, et al. · Lancet (London, England) · 2017 · Systematic review DOIPubMed 29050646
  20. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Peyrin-Biroulet L, Sandborn W, Sands BE, et al. · The American journal of gastroenterology · 2015 · Systematic review DOIPubMed 26303131
  21. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis Li F, Liu X, Wang W, et al. · European journal of gastroenterology & hepatology · 2015 · Meta-analysis DOIPubMed 25831134
  22. How IBD patients cope with IBD: a systematic review McCombie AM, Mulder RT, Gearry RB · Journal of Crohn's & colitis · 2013 · Systematic review DOIPubMed 22718016
  23. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis Lee TW, Kolber MR, Fedorak RN, et al. · Journal of Crohn's & colitis · 2012 · Meta-analysis DOIPubMed 22405161
  24. Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial Younginer ST, Westbrook A, Buzenski J, et al. · Journal of pediatric gastroenterology and nutrition · 2026 · Randomised controlled trial DOIPubMed 41486461Full text
  25. Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial Kamp K, Yoo L, Kale T, et al. · Digestive diseases and sciences · 2026 · Randomised controlled trial DOIPubMed 42470576Full text
  26. Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial Roukas C, Miller L, Büttner FC, et al. · BMJ open gastroenterology · 2026 · Randomised controlled trial DOIPubMed 42386349Full text
  27. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Ferrante M, D'Haens G, Jairath V, et al. · Lancet (London, England) · 2024 · Randomised controlled trial DOIPubMed 39581202
  28. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme Danese S, Dignass A, Matsuoka K, et al. · Journal of Crohn's & colitis · 2024 · Randomised controlled trial DOIPubMed 38869019Full text
  29. Acceptance and Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress: A Randomized Controlled Trial Naude C, Skvarc D, Maunick B, et al. · The American journal of gastroenterology · 2024 · Randomised controlled trial DOIPubMed 39162706Full text
  30. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial Truyens M, Lobatón T, Ferrante M, et al. · Gastroenterology · 2022 · Randomised controlled trial DOIPubMed 35940251
  31. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  32. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al. · The New England journal of medicine · 2019 · Randomised controlled trial DOIPubMed 31553834
  33. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies Caron B, Honap S, Peyrin-Biroulet L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475082Full text
  34. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life Nguyen TV, Damiani G, Orenstein LAV, et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · Review DOIPubMed 32460374
  35. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review Mahadea D, Adamczewska E, Ratajczak AE, et al. · Nutrients · 2021 · Review DOIPubMed 34836263Full text
  36. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Elmets CA, Leonardi CL, Davis DMR, et al. · Journal of the American Academy of Dermatology · 2019 · Review DOIPubMed 30772097
  37. Fatigue in inflammatory bowel disease Grimstad T, Norheim KB · Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2016 · Review DOIPubMed 27830906
  38. Global evolution of inflammatory bowel disease across epidemiologic stages Hracs L, Windsor JW, Gorospe J, et al. · Nature · 2025 · Journal article DOIPubMed 40307548Full text
  39. Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease Parigi TL, Massimino L, Carini A, et al. · Journal of Crohn's & colitis · 2025 · Journal article DOIPubMed 39269323
  40. Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study Zhang J, Liu C, An P, et al. · United European gastroenterology journal · 2024 · Journal article DOIPubMed 38315582Full text

Šī lapa tika automātiski tulkota no angļu valodas. Atsauces un skaitļi paliek nemainīgi. Izlasiet angļu oriģinālu, ja kaut kas šķiet dīvaini. Izlasīt angļu oriģinālu